Your gateway to Asia Pacific from anywhere in the world
Discover how JLABS can accelerate your success.
A global innovation hub without geographic barriers
Leveraging the innovation resources and connectivity of JLABS, Johnson & Johnson's global incubator network, JLABS Singapore connects life science and healthcare innovators to one of the world’s most advanced biomedical ecosystems without requiring you to relocate. As the gateway to the Asia Pacific region, Singapore offers strategic proximity to Johnson & Johnson's global network, regional healthcare systems, world-class research institutions and high-growth patient populations. And through our virtual membership model, you can access these advantages from anywhere.
Empowering entrepreneurs around the globe
Industry expertise
Utilize our JPALS network to gain access to Johnson & Johnson's global network of experts.
Access to venture connections
JLABS can provide access to venture connections for potential funding opportunities.
JLABS Singapore portfolio highlights
© Johnson & Johnson and its affiliates 2026. All rights reserved.
total raised by companies (secured and contingent)
US $2.3B
1
50
companies (current and alumni) within the ecosystem
IPO
The data reflected in portfolito highlights is based on statistics collected in January 2026.
Networking opportunities
Leverage connections across Asia Pacific, North America, and Europe.
Our virtual model
JLABS Singapore operates as a virtual incubation program designed to provide startups with seamless access to a comprehensive range of resources.